Skip to main content
Journal cover image

Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.

Publication ,  Journal Article
Akbar, M; Abel, R; Seyler, TM; Bedke, J; Haferkamp, A; Gerner, HJ; Möhring, K
Published in: BJU Int
September 2007

OBJECTIVES: To examine the effects of repeated detrusor injections of botulinum-A toxin (BTX) for possible changes in bladder function, muscular structure of the detrusor, increase in BTX tolerance (tachyphylaxis) and side-effects, as BTX is a new treatment alternative for patients with a neurogenic bladder condition that is difficult to treat and refractory to anticholinergic medication. PATIENTS AND METHODS: Between 2000 and 2005, 19 patients with myelodysplasia (MDP) and 25 spinal cord-injured (SCI) patients were treated with repeated suburothelial BTX injections (Dysport, Ipsen-Pharma, Ettlingen, Germany) or injections into the intramural detrusor. The follow-up was > or = 3 years (range 3-5, median 4.5). RESULTS: Detrusor compliance, bladder capacity, and detrusor pressure at maximum filling improved significantly (P < 0.001) compared to baseline after each BTX injection. There was prolonged efficacy of each BTX administration and all repeated injections in the paediatric and adult patients with neurogenic bladder dysfunction over a median follow-up of 4.5 years. There was no evidence for drug tolerance or changes in the morphological appearance of the bladder. Safety was good: no complications were associated with the injection procedure itself. Early in the treatment programme, three patients who received a dose of 1000 units Dysport showed systemic side-effects and generalized muscle weakness. These resolved without intervention and did not recur after reducing the adult dose to 750 units (paediatric dose 20 units/kg, not >400 units), which seems to be the optimum for good efficacy with an adequate safety margin. CONCLUSION: BTX injection is a safe and effective treatment for neurogenic detrusor hyperreflexia. Repeat treatments are as effective as the first: there was no indication of a lack of efficacy due to tachyphylaxis, antibody formation, or fibrosis of the detrusor muscle in this sample.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BJU Int

DOI

ISSN

1464-4096

Publication Date

September 2007

Volume

100

Issue

3

Start / End Page

639 / 645

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Urodynamics
  • Urinary Bladder, Neurogenic
  • Treatment Outcome
  • Spinal Cord Injuries
  • Retrospective Studies
  • Neuromuscular Agents
  • Neural Tube Defects
  • Male
  • Injections
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Akbar, M., Abel, R., Seyler, T. M., Bedke, J., Haferkamp, A., Gerner, H. J., & Möhring, K. (2007). Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int, 100(3), 639–645. https://doi.org/10.1111/j.1464-410X.2007.06977.x
Akbar, Michael, Rainer Abel, Thorsten M. Seyler, Jens Bedke, Axel Haferkamp, Hans J. Gerner, and Klaus Möhring. “Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.BJU Int 100, no. 3 (September 2007): 639–45. https://doi.org/10.1111/j.1464-410X.2007.06977.x.
Akbar, Michael, et al. “Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.BJU Int, vol. 100, no. 3, Sept. 2007, pp. 639–45. Pubmed, doi:10.1111/j.1464-410X.2007.06977.x.
Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, Möhring K. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int. 2007 Sep;100(3):639–645.
Journal cover image

Published In

BJU Int

DOI

ISSN

1464-4096

Publication Date

September 2007

Volume

100

Issue

3

Start / End Page

639 / 645

Location

England

Related Subject Headings

  • Urology & Nephrology
  • Urodynamics
  • Urinary Bladder, Neurogenic
  • Treatment Outcome
  • Spinal Cord Injuries
  • Retrospective Studies
  • Neuromuscular Agents
  • Neural Tube Defects
  • Male
  • Injections